Czech Republic
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic Growth
Revenue: $45 million in Q3, down 5% year-over-year; $128 million year-to-date, down 9% versus 2023.Consumables Revenue: $14 million in Q3, up 13% year-over-yea